Adding NAC does not automatically make glutathione more effective, and a biochemical relationship does not establish that a combination is safe for every person. The desired outcome and the exact interventions still need to be defined.
A small crossover study compared NAC with specified oral and sublingual glutathione preparations using oxidative-stress and glutathione measurements. It was not a trial showing that combining all of them improves cognition, skin appearance or long-term health.
Comparison and combination are different designs
When a study compares separate treatments, it can inform questions about those treatments under the study conditions. It cannot establish what happens when they are taken simultaneously.
A combination trial would need its own groups, outcomes and adverse-event collection. It would also need to distinguish an added benefit from a response that either component could produce alone.
The same principle applies to research on glycine with NAC. A result for that defined combination cannot be silently relabeled as evidence for glutathione plus NAC, or for a larger supplement stack.
More ingredients make attribution harder
If sleep, mood or concentration changes after several supplements are introduced, it may be difficult to identify which exposure mattered. A complex biological explanation offered online does not reliably resolve that uncertainty.
The report can still be useful to a clinician. A clear timeline, ingredient lists and existing medicines are more informative than assuming that a particular neurotransmitter pathway explains the symptoms.
This is also why one person's adverse experience should not be converted into a universal claim that the combination is always dangerous. The evidence may be insufficient to quantify the risk in either direction.
A clinical decision should begin with whether there is a supported reason to use any of the ingredients for the intended goal. If that foundation is missing, adding another precursor does not supply it.
The inspected comparison provides narrow biomarker information, not a stacking protocol or a personal substitution ratio. Persistent cognitive, mood or sleep changes deserve assessment rather than attempts to rebalance them with further untested additions.